Cargando…

DNA Polymerases as targets for gene therapy of hepatocellular carcinoma

BACKGROUND: Hepatocyte carcinoma (HCC) is one of the most common malignancies worldwide. Despite many achievements in diagnosis and treatment, HCC mortality remains high due to the malignant nature of the disease. Novel approaches, especially for targeted therapy, are being extensively explored. Gen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Hao, Wei, Qun, Wang, Jia, Huang, Xiaoming, Li, Chunchun, Zheng, Qiaoli, Cao, Jiang, Jia, Zhenyu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4423151/ https://www.ncbi.nlm.nih.gov/pubmed/25924900 http://dx.doi.org/10.1186/s12885-015-1339-1

Ejemplares similares

The Mechanism and Prognostic Value of DNA Polymerase δ Subunits in Hepatocellular Carcinoma: Implications for Precision Therapy
por: Wang, Qing, et al.
Publicado: (2022)

Cell-specific expression of artificial microRNAs targeting essential genes exhibit potent antitumor effect on hepatocellular carcinoma cells
por: Mao, Chenyu, et al.
Publicado: (2015)

Nuclear distribution of eIF3g and its interacting nuclear proteins in breast cancer cells
por: ZHENG, QIAOLI, et al.
Publicado: (2016)

A novel multikinase inhibitor R8 exhibits potent inhibition on cancer cells through both apoptosis and autophagic cell death
por: Xie, Yuqiong, et al.
Publicado: (2017)

Targeted therapy for hepatocellular carcinoma
por: Huang, Ao, et al.
Publicado: (2020)

Editorial: Interventional therapy of hepatocellular carcinoma
por: Ji, Jiansong, et al.
Publicado: (2022)

Nosip is a potential therapeutic target in hepatocellular carcinoma cells
por: Gao, Junjie, et al.
Publicado: (2023)

DDX11-AS1 as potential therapy targets for human hepatocellular carcinoma
por: Shi, Min, et al.
Publicado: (2017)

Spleen‐targeted neoantigen DNA vaccine for personalized immunotherapy of hepatocellular carcinoma
por: Wu, Ming, et al.
Publicado: (2023)

Targeted Therapy in Hepatocellular Carcinoma
por: Chua, Clarinda W. L., et al.
Publicado: (2011)

Construction of HCC-targeting artificial miRNAs using natural miRNA precursors
por: HUANG, XIAOMING, et al.
Publicado: (2013)

Localization of hepatitis B virus DNA in hepatocellular carcinoma by polymerase chain reaction in situ hybridization.
por: Shin, Y. J., et al.
Publicado: (1998)

Recent advances in oncolytic virus therapy for hepatocellular carcinoma
por: Zhu, Licheng, et al.
Publicado: (2023)

Poly(ADP-Ribose) Polymerase Inhibition as a Promising Approach for Hepatocellular Carcinoma Therapy
por: Paturel, Alexia, et al.
Publicado: (2022)

Downregulated Ferroptosis-Related Gene STEAP3 as a Novel Diagnostic and Prognostic Target for Hepatocellular Carcinoma and Its Roles in Immune Regulation
por: Yan, Yuanliang, et al.
Publicado: (2021)

MicroRNA-499 Suppresses the Growth of Hepatocellular Carcinoma by Downregulating Astrocyte Elevated Gene-1
por: Wang, Jing, et al.
Publicado: (2020)

Advances of Targeted Therapy for Hepatocellular Carcinoma
por: Niu, Mengke, et al.
Publicado: (2021)

Radiation therapy in the era of immune treatment for hepatocellular carcinoma
por: Chen, Lingjuan, et al.
Publicado: (2023)

Increased DNA Polymerase Epsilon Catalytic Subunit Expression Predicts Tumor Progression and Modulates Tumor Microenvironment of Hepatocellular Carcinoma
por: Tang, Haijia, et al.
Publicado: (2022)

DNA polymerase iota (Pol ι) promotes invasion and metastasis of esophageal squamous cell carcinoma
por: Zou, Shitao, et al.
Publicado: (2016)

Dual-Targeting Nanoparticle-Mediated Gene Therapy Strategy for Hepatocellular Carcinoma by Delivering Small Interfering RNA
por: Zheng, Qi Chang, et al.
Publicado: (2020)

The Value of Survivin Gene and Proliferation of Hepatocytes in Screening for Hepatocellular Carcinoma
por: Jia, Ke Dong, et al.
Publicado: (2009)

Elevated DNA Polymerase Delta 1 Expression Correlates With Tumor Progression and Immunosuppressive Tumor Microenvironment in Hepatocellular Carcinoma
por: Zhao, Shuai, et al.
Publicado: (2021)

Transarterial embolization/chemoembolization therapy for hepatocellular carcinoma fed by adrenal artery: Preliminary results
por: Hu, Shibing, et al.
Publicado: (2016)

DNA polymerases as chemotherapy targets: promise and challenges
por: Eckert, Kristin A., et al.
Publicado: (2019)

Circulating tumor DNA in hepatocellular carcinoma: trends and challenges
por: Tang, Jia-Cheng, et al.
Publicado: (2016)

Targeted Therapies in the Treatment of Advanced Hepatocellular Carcinoma
por: Wei, Zhengyu, et al.
Publicado: (2013)

Hepatocellular carcinoma-targeted nanoparticles for cancer therapy
por: Wu, Chien-Hsun, et al.
Publicado: (2017)

Hepatocellular Carcinoma: Molecular Mechanisms and Targeted Therapies
por: Alqahtani, Ali, et al.
Publicado: (2019)

Glypican 3-Targeted Therapy in Hepatocellular Carcinoma
por: Nishida, Takahiro, et al.
Publicado: (2019)

Apatinib as an alternative therapy for advanced hepatocellular carcinoma
por: Zhang, Xi-Hao, et al.
Publicado: (2020)

Prognostic comparative genes predict targets for sorafenib combination therapies in hepatocellular carcinoma
por: Ho, Chun-Ming, et al.
Publicado: (2022)

Bioinformatics analysis of the gene expression profile of hepatocellular carcinoma: preliminary results
por: Li, Jia, et al.
Publicado: (2016)

Identification and Validation of Key Genes in Hepatocellular Carcinoma by Bioinformatics Analysis
por: Wang, Jia, et al.
Publicado: (2021)

Exploration of Sorafenib Influences on Gene Expression of Hepatocellular Carcinoma
por: Wang, Huancheng, et al.
Publicado: (2020)

Corrigendum: Dual-Targeting Nanoparticle-Mediated Gene Therapy Strategy for Hepatocellular Carcinoma by Delivering Small Interfering RNA
por: Zheng, Qi Chang, et al.
Publicado: (2021)

Prognostic value of DNA repair based stratification of hepatocellular carcinoma
por: Lin, Zhuo, et al.
Publicado: (2016)

Hepatocellular carcinoma detection via targeted enzymatic methyl sequencing of plasma cell-free DNA
por: Guo, Ping, et al.
Publicado: (2023)

Effects of transarterial chemoembolization combined with antiviral therapy on HBV reactivation and liver function in HBV-related hepatocellular carcinoma patients with HBV-DNA negative
por: Wang, Kai, et al.
Publicado: (2018)

The potential of epigallocatechin gallate in the chemoprevention and therapy of hepatocellular carcinoma
por: Li, Dongming, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_l75h8ksejj34illeahsp32risd